Through intravitreal administration and in vitro mimic transfection, miR-205-5p effectively restored VEGFA levels and inhibited key processes such as angiogenesis and migration, which are central to the progression of diabetic retinopathy. Here, VEGFA is linked to diabetic retinopathy.